Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

exudative macular degeneration

APEX: a phase II randomised clinical trial evaluating the safety and preliminary efficacy of oral X-82 to treat exudative age-related macular degeneration
Michael N. Cohen, Denis O’Shaughnessy, Kate Fisher, Jennifer Cerami, Carl C Awh, Daniel E Salazar, Philip Rosenfeld, Jeffrey S Heier

British Journal of Ophthalmology May 2021, 105 (5) 716-722; DOI: 10.1136/bjophthalmol-2020-316511